Justices Deny Eli Lilly's Qui Tam Constitutional Challenge
By Madeline Lyskawa · May 18, 2026, 1:39 PM EDT
The U.S. Supreme Court on Monday declined to review Eli Lilly's $183 million trial loss to a whistleblower who claimed the drugmaker knowingly defrauded the government by underpaying Medicaid drug rebates....
To view the full article, register now.